title: [Gastrointestinal stomal tumours, morphology and molecular pathology].
abstract: Gastointestinal stromal tumours (GIST) are the most common mesenchymal neoplasms of the digestive tract. They originate from the interstitial cells of Cajal. GIST are not regarded as benign tumours, and morphological risk assessment is generally recommended according to the NIH consensus adapted from Fletcher et al. Other classifications (Miettinen and Lasota, Joensuu) considering the tumour site and tumour integrity as individual criterion may give different assessment results. Therefore, a special note has to be given in a proper histopathological diagnosis, referring to the system of risk assessment used. The histological diagnosis of GIST requires immunohistochemistry (CD117, PDGFRalpha). In doing so the use of a panel of antibodies is recommended helpful to cover all differential diagnostic relevant possibilities of mesenchymal neoplasms of the digestive tract. Analysis of the hot spot regions of KIT and PDGFRalpha genes is important for therapy planning and also may have some prognostic significance, for which reason it is recommended to be performed in GIST regularly.
authors.affiliation: Institut für Klinische Pathologie, Medizinische Universität Wien, Wien, Osterreich. fritz.wrba@meduniwien.ac.at
authors.forename: Fritz
authors.initials: F
authors.lastname: Wrba
mesh_terms: D000075369:Anoctamin-1; D014408:Biomarkers, Tumor / Q000032:analysis; D044963:Biopsy, Fine-Needle; D018118:Chloride Channels; D004252:DNA Mutational Analysis; D003937:Diagnosis, Differential; D005753:Gastric Mucosa / Q000473:pathology; D046152:Gastrointestinal Stromal Tumors / Q000235:genetics* / Q000473:pathology*; D041981:Gastrointestinal Tract / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007413:Intestinal Mucosa / Q000473:pathology; D008565:Membrane Proteins / Q000235:genetics; D008940:Mitotic Index; D009363:Neoplasm Proteins / Q000235:genetics; D011379:Prognosis; D019009:Proto-Oncogene Proteins c-kit / Q000032:analysis / Q000235:genetics*; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*
chemical_list: C476213:ANO1 protein, human; D000075369:Anoctamin-1; D014408:Biomarkers, Tumor; D018118:Chloride Channels; D008565:Membrane Proteins; D009363:Neoplasm Proteins; D019009:Proto-Oncogene Proteins c-kit; D020796:Receptor, Platelet-Derived Growth Factor alpha
references.citation: Science. 1998 Jan 23;279(5350):577-80
references.pmid: 9438854
references.citation: Am J Surg Pathol. 2004 Apr;28(4):479-88
references.pmid: 15087667
references.citation: Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4089-95
references.pmid: 15217944
references.citation: Hum Pathol. 2008 Oct;39(10):1411-9
references.pmid: 18774375
references.citation: Am J Surg Pathol. 2009 Mar;33(3):437-46
references.pmid: 19011564
references.citation: Gastroenterology. 1999 Jul;117(1):140-8
references.pmid: 10381920
references.citation: Hum Pathol. 2002 May;33(5):459-65
references.pmid: 12094370
references.citation: Arch Pathol Lab Med. 2006 Oct;130(10):1466-78
references.pmid: 17090188
references.citation: Proc Natl Acad Sci U S A. 2003 May 27;100(11):6706-11
references.pmid: 12754375
references.citation: Am J Pathol. 1998 May;152(5):1259-69
references.pmid: 9588894
references.citation: Cancer Res. 2005 Aug 1;65(15):6631-9
references.pmid: 16061643